Results 31 to 40 of about 1,222 (146)

Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review

Pulmonary Circulation, 2021
This systematic review of literature and online reports critically appraised incidence and prevalence estimates of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension to identify the most accurate estimates.
Laurence Leber, Amélie Beaudet, Audrey Muller   +2 more
doaj   +1 more source

Case report: Central venous catheter thrombosis complicated by chronic thromboembolic disease/pulmonary hypertension in two children requiring parenteral nutrition

Frontiers in Cardiovascular Medicine, 2023
Chronic thromboembolic pulmonary hypertension is a rare but life-threatening complication of long-term central venous catheters (CVC) in children. However, evidence in terms of potential treatment strategies and outcome data remains scarce.
Maja Hanuna, Joseph Pattathu, Joscha Buech, Joscha Buech, Christine Kamla, Nikolaus Kneidinger, Nikolaus Kneidinger, Juergen Behr, Juergen Behr, Katrin Milger, Katrin Milger, Tobias Veit, Tobias Veit, Marina Nagel, Jan Abicht, Robert Dalla-Pozza, Marcus Fischer, Andre Jakob, Matthias Hermann, Rene Schramm, Laura L. Rosenthal, Nikolaus Haas, Jürgen Hörer, Jürgen Hörer, Christian Hagl, Christian Hagl, Christian Hagl, Sebastian G. Michel, Sebastian G. Michel, Sebastian G. Michel, Sebastian G. Michel, Sebastian G. Michel   +31 more
doaj   +1 more source

Chronic thromboembolic pulmonary hypertension: a review [PDF]

Singapore Medical Journal, 2021
Chronic thromboembolic pulmonary hypertension (CTEPH) is a unique form of pulmonary hypertension resulting from obstruction of the pulmonary artery by fibrotic thromboembolic material, usually initiated by recurrent or incomplete resolution of pulmonary embolism.
Cheryl Zhiya, Chong, Edgar Lik Wui, Tay, Ching Hui, Sia, Kian Keong, Poh   +3 more
openaire   +2 more sources

A computational model of contributors to pulmonary hypertensive disease: impacts of whole lung and focal disease distributions

Pulmonary Circulation, 2021
Pulmonary hypertension has multiple etiologies and so can be difficult to diagnose, prognose, and treat. Diagnosis is typically made via invasive hemodynamic measurements in the main pulmonary artery and is based on observed elevation of mean pulmonary ...
Behdad Shaarbaf Ebrahimi, Merryn H. Tawhai, Haribalan Kumar, Kelly S. Burrowes, Eric A. Hoffman, Margaret L. Wilsher, David Milne, Alys R. Clark   +7 more
doaj   +1 more source

A CASE REPORT OF CHRONIC PULMONARY THROMBOEMBOLISM AND ACCOMPANYING CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: CHRONIC PULMONARY THROMBOEMBOLISM AND HYPERTENSION

Acta Medica Leopoliensia, 2022
Aim. Our paper aims to discuss the radiological and clinical findings of chronic pulmonary embolism (CPTE) and chronic thromboembolic pulmonary hypertension (CTEPH) over the patient's findings. Material and Methods. We present the case of a 49-year-old female patient with CPTE and CTEPH. Results and Discussion.
Emrah Dogan, Ozge Oral Tapan, Utku Tapan, Sabri Serhan Olcay   +3 more
openaire   +2 more sources

Balloon Pulmonary Angioplasty: State of the Art

Interventional Cardiology: Reviews, Research, Resources, 2021
Balloon pulmonary angioplasty (BPA) is a novel technique for the treatment of chronic thromboembolic pulmonary hypertension. While cardiologists need no introduction to the concept of balloon angioplasty, BPA has its own particular challenges.
John G Coghlan, Alexander MK Rothman, Stephen P Hoole   +2 more
doaj   +1 more source

Riociguat use in sickle cell related chronic thromboembolic pulmonary hypertension: A case series

Pulmonary Circulation, 2018
Adults with sickle cell disease can develop pulmonary hypertension from a multitude of etiologies. Classified as WHO Group 5, there are no therapies approved for the treatment of sickle cell disease-pulmonary hypertension.
Nargues A. Weir, Anna Conrey, Denise Lewis, Alem Mehari   +3 more
doaj   +1 more source

Time trends of pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension

Pulmonary Circulation, 2021
Chronic thromboembolic pulmonary hypertension is considered as a rare but severe complication after acute pulmonary embolism and is potentially curable by pulmonary endarterectomy.
Lukas Hobohm, Karsten Keller, Thomas Münzel, Stavros V. Konstantinides, Mareike Lankeit   +4 more
doaj   +1 more source

Balloon pulmonary angioplasty: a treatment option for inoperable patients with chronic thromboembolic pulmonary hypertension

Frontiers in Cardiovascular Medicine, 2015
In chronic thromboembolic pulmonary hypertension, stenoses or obstructions of the pulmonary arteries due to organized thrombi can cause an elevation in pulmonary artery resistance, which in turn can result in pulmonary hypertension.
Aiko eOgawa, Hiromi eMatsubara
doaj   +1 more source

Real‐World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the EUSTAR Cohort

Arthritis Care &Research, EarlyView.
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato, Marie‐Elise Truchetet, Marco Minerba, Oliver Distler, Juan José Alegre Sancho, Yolanda Braun‐Moscovici, Christina Bergmann, Petros Sfikakis, Jeska K. de Vries‐Bouwstra, Murray Baron, Silvia Bellando‐Randone, Lorenzo Dagna, Christopher P. Denton, Madelon C. Vonk, Vanessa Smith, Ivan Castellvi, Gabriela Riemekasten, Andra Balanescu, Masataka Kuwana, Maria De Santis, Kamal Solanki, Anastas Batalov, Vahan Mukuchyan, Marco Matucci‐Cerinic, Yannick Allanore, Francesco Del Galdo, Michael Hughes, EUSTAR Collaborators   +27 more
wiley   +1 more source